GlassScriptPhysician profile
Mindy K Rathe
NPI 1730270117
$823.95
in general payments reported to CMS, 2019-2025
12 companies · $489 in 2025
The $489 reported for 2025 was more than what 83% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2024: $192 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.59 | 2024-2025 | |
| Medtronic, INC. | $165.26 | 2025 | Interstim |
| Axonics, INC. | $142.71 | 2022 | |
| Sumitomo Pharma America, INC. | $132.52 | 2024-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $73.61 | 2025 | Veozah |
| Octapharma USA, INC. | $34.54 | 2025 | Fibryga |
| Organon LLC | $22.82 | 2024 | |
| Coloplast Corp | $19.45 | 2024 | |
| 180 Medical, INC. | $19.41 | 2025 | |
| Exeltis, USA INC. | $14.51 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $13.47 | 2024 | |
| Mayne Pharma Commercial LLC | $8.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Rathe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.